Absci Corp
(NAS:ABSI)
$
2.99
-0.16 (-5.08%)
Market Cap: 343.42 Mil
Enterprise Value: 246.72 Mil
PE Ratio: 0
PB Ratio: 1.79
GF Score: 55/100 Absci Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2023 / 11:30AM GMT
Release Date Price:
$1.66
(+3.11%)
Vikram Purohit
Morgan Stanley & Co. LLC - Analyst
Okay. Good morning, everyone. Go ahead and get started. Apologies for the slightly delayed start. We'll make it up on the back end.
My name is [Vikram Purohit]. I'm one of the biotech analysts with the Morgan Stanley research team. Happy to have with me the team from Absci. But first, let me read the research disclosure statement. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative. I'll catch my breath from running over here from the wrong room.
Sean, thanks for joining us. Appreciate it.
Sean McClain
Absci Corporation - Founder, CEO & Director
Absolutely. Thanks for having us here.
Questions & Answers
Vikram Purohit
Morgan Stanley & Co. LLC - Analyst
A lot of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot